Cephalexin
Product Images NDC 21695-551

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 21695-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cephalexin Structural Formula (4e334e50 19c4 449b B77f 549a461c7f84 01)

Cephalexin Structural Formula (4e334e50 19c4 449b B77f 549a461c7f84 01)
Chemical structure of Cephalexin showing its molecular composition including a β-lactam ring, a thiazolidine ring, and associated functional groups, depicted with water molecule (H2O) as part of the structure.*
FDA Label Image

Cephalexin 250mg/5ml Suspension 100ml (4e334e50 19c4 449b B77f 549a461c7f84 02)

Cephalexin 250mg/5ml Suspension 100ml (4e334e50 19c4 449b B77f 549a461c7f84 02)
Cephalexin 250mg/5ml Suspension 100ml oral suspension label distributed by Physician Partner and manufactured by Teva Pharmaceuticals USA. The label includes dosing information, reconstitution instructions with 71ml water (berry flavored), lot number, expiration date placeholders, and the Product ID RC055100. Stored at controlled room temperature with a warning to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.